Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
Nia JulianMay 20, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines

Nia JulianMay 21, 2020
Next

Rallybio Completes $145 Million Series B Financing and Announces Plans to Advance Lead Product Candidate into the Clinic in 2H 2020

Nia JulianMay 19, 2020

© 2020 Solasta Ventures. All Rights Reserved.